Origin Bancorp's Q3 profit hit by a $35.2M fraud charge, but the company's strategic investments and efficiency initiatives are expected to boost future earnings.
Partisan gridlock over ePTC fight keeps government shutdown in fourth week, with both sides blaming the other and voters divided on who's at fault.
Pfizer sues Novo Nordisk to block its $8.5-$9B bid for Metsera, alleging antitrust violations and a 'kill' strategy to preserve dominance in GLP-1 obesity drugs.
Origin Bancorp's Q3 profit hit by a $35.2M fraud charge, but the company's strategic investments and efficiency initiatives are expected to boost future earnings.
Partisan gridlock over ePTC fight keeps government shutdown in fourth week, with both sides blaming the other and voters divided on who's at fault.
Pfizer sues Novo Nordisk to block its $8.5-$9B bid for Metsera, alleging antitrust violations and a 'kill' strategy to preserve dominance in GLP-1 obesity drugs.